摘要 |
The invention relates to a process for the preparation of novel 3H,5H-1,2,4-triazolo[1,5-a]pyrimidines, which are used for the therapy of cardiovascular disorders. According to the invention, the hydriodides of 1,4-dihydro-1-acylamino-2-methylthiopyrimidines are reacted with ammonia or amines in the form of their ammonium acetates in glacial acetic acid in a 1-pot reaction and 3H,5H-1,2,4-triazolo[1,5-a]pyrimidines are obtained by elimination of methanethiol and water.
|
申请人 |
VEB DEUTSCHES HYDRIERWERK RODLEBEN |
发明人 |
BRUESEHABER,LUDWIG,DIPL.-CHEM.DR.;HEYDENHAUSS,DIETRICH,DIPL.-CHEM.DR.;HOELZEL,HORST,DIPL.-CHEM.DR.;JAENECKE,GUENTER,PROF.DIPL.-CHEM.DR.;KONETZKE,GERHARD,DIPL.-CHEM.DR.;MEISTER,LIESELOTTE,DIPL.-CHEM.;RICHTER,RENATE,DIPL.-CHEM.DR.;ROETHLING,TILO,DIPL.-CHEM.DR.;TENOR,ERNST,DIPL.-CHEM.DR.;THOMAS,ECKHARD,DIPL.-BIOL.;VOIGT,HARRY,DR. |